Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Integral Diagnostics Ltd. ( (AU:IDX) ) has shared an update.
Integral Diagnostics Ltd. has announced a change in its Company Secretary roles, effective from January 20, 2025. Mr. John Merity has been appointed as the permanent Company Secretary, transitioning from his interim role. Meanwhile, Ms. Nikki Dalla Valle will step down from her Company Secretary position but will continue her responsibilities as General Counsel, overseeing Legal and Risk. These changes are expected to streamline operations and reinforce the company’s leadership structure.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand, employing some of Australasia’s top radiologists and diagnostic imaging specialists. The company operates under a medical leadership model focused on quality patient care, service, and access.
YTD Price Performance: 1.72%
Average Trading Volume: 886,960
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$1.1B
See more insights into IDX stock on TipRanks’ Stock Analysis page.
